September 23, 2020 –The U.S. FDA is requiring an update to the black box warning – the agency’s most prominent safety warning on drug labels – for benzodiazepines. The warning describes
September 22, 2020 –Perrigo has voluntarily recalled all unexpired albuterol sulfate inhalation aerosol
manufactured by Catalent Pharma Solutions for Perrigo. The recall is due to possible
September 17, 2020 –Acella Pharmaceuticals has voluntarily recalled one lot of 15mg and one lot of 120mg NP Thyroid®, Thyroid Tablets, USP (levothyroxine and liothyronine) due
September 17, 2020 –The U.S. FDA has withdrawn approval for Belviq® (lorcaserin HCl) and Belviq XR®
(lorcaserin HCl extended release), manufactured by Eisai. Both drugs were indicated
September 9, 2020 –The U.S. FDA has approved Qdolo® (tramadol) 5mg/mL oral solution, manufactured by Athena Biosciences. The drug is indicated to manage pain severe enough to require
September 9, 2020 –The U.S. FDA has approved a new indication for Trelegy® ElliptaTM (fluticasone
furoate/umeclidinium/vilanterol) oral inhalation powder, manufactured by GlaxoSmithKline
September 7, 2020 –The U.S. FDA has approved GavretoTM (pralsetinib), manufactured by Roche, to treat
adults diagnosed with metastatic rearranged-during-transfection (RET) fusion-positive
September 1, 2020 –The U.S. FDA has approved the MiniMedTM 770G hybrid closed loop insulin pump
system, manufactured by Medtronic. According to the FDA, “it is the first legally marketed